Ethics & Informed Consent: Systematic Review & Meta-Analysis (New Zealand)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Systematic Review & Meta-Analysis being conducted in New Zealand, study designs must align with the primary regulatory legislation: National Ethical Standards for Health and Disability Research. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Health and Disability Ethics Committee (HDEC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Systematic Review & Meta-Analysis, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Exempt (No Human Participant Recruitment)

Meta-analyses rely on previously published scholarly studies. The project does not recruit active subjects, making it exempt from direct human ethics board audits.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: PRISMA declaration.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Privacy Act 2020 & Health Information Privacy Code.
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Health and Disability Ethics Committee (HDEC) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Evaluating source publications in this Systematic Review & Meta-Analysis in New Zealand relies on the Belmont Report principles of justice and academic honesty. The synthesis should screen primary works to ensure that no hidden deception in psychological research compromised patient safety. The secondary nature of this review means that individual research study consent form files are not gathered under informed consent Belmont Report rules. While we bypass standard clinical trial registration and a clinical trial agreement contract, registering the protocol on PROSPERO is recommended. The analysis does not use live animals, removing any need for the 3rs replacement reduction refinement protocols. In accordance with New Zealand participant safety rules, investigators must complete certified human protection modules before recruitment begins.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions